GlucoTrack Statistics
Total Valuation
GlucoTrack has a market cap or net worth of $4.05 million. The enterprise value is -$1.40 million.
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GlucoTrack has 25.59 million shares outstanding. The number of shares has increased by 59.04% in one year.
| Current Share Class | 25.59M |
| Shares Outstanding | 25.59M |
| Shares Change (YoY) | +59.04% |
| Shares Change (QoQ) | +84.92% |
| Owned by Insiders (%) | 0.84% |
| Owned by Institutions (%) | 0.18% |
| Float | 22.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | -0.30 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.52
| Current Ratio | 4.52 |
| Quick Ratio | 4.41 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -23.16 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -167.79% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -312.37% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.05M |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.67% in the last 52 weeks. The beta is 0.02, so GlucoTrack's price volatility has been lower than the market average.
| Beta (5Y) | 0.02 |
| 52-Week Price Change | -99.67% |
| 50-Day Moving Average | 0.28 |
| 200-Day Moving Average | 19.05 |
| Relative Strength Index (RSI) | 33.44 |
| Average Volume (20 Days) | 1,989,072 |
Short Selling Information
The latest short interest is 43,631, so 0.17% of the outstanding shares have been sold short.
| Short Interest | 43,631 |
| Short Previous Month | 283,937 |
| Short % of Shares Out | 0.17% |
| Short % of Float | 0.19% |
| Short Ratio (days to cover) | 0.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.55M |
| Pretax Income | -7.56M |
| Net Income | -22.60M |
| EBITDA | -14.51M |
| EBIT | -14.55M |
| Earnings Per Share (EPS) | -$68.44 |
Full Income StatementBalance Sheet
The company has $5.62 million in cash and $267,000 in debt, giving a net cash position of $5.35 million or $0.21 per share.
| Cash & Cash Equivalents | 5.62M |
| Total Debt | 267,000 |
| Net Cash | 5.35M |
| Net Cash Per Share | $0.21 |
| Equity (Book Value) | -13.00M |
| Book Value Per Share | -16.42 |
| Working Capital | 4.49M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$12.49 million and capital expenditures -$104,000, giving a free cash flow of -$12.59 million.
| Operating Cash Flow | -12.49M |
| Capital Expenditures | -104,000 |
| Free Cash Flow | -12.59M |
| FCF Per Share | -$0.49 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |